The role of angiotensin receptors in cardiovascular diseases

Annals of Medicine

Volumn 29, Issue 1, 1997, Pages 23-29

  Helin, Karri ^a   Stoll, Monika ^b   Meffert, Simone ^b   Stroth, Ursula ^b   Unger, Thomas ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiogenesis; Angiotensin II receptors; Differentiation; Endothelium; Growth; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIOGENESIS; CARDIOVASCULAR DISEASE; HEART MUSCLE; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031025672     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899708998740     Document Type: Review

References (67)

1. Casis LA, Saye JA, Peach MJ. Localization and regulation of rat angiotensinogen mRNA. Hypertension 1988; 11: 591-6.
2. Danser AH, Sassen LM, Admiraal PJ, Derkx FH, Verdouw PD, Schalekamp MA. Regional production of angiotensins I and II: contribution of vascular kidney-derived renin. J Hypertens 1991; 9 (Suppl. 6): S234-5.
3. Wang D, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990; 15: 68-77.
4. Dahlof B. The importance of the renin-angiotensin system in the reversal of left ventricular hypertrophy. J Hypertens 1993; 11 (Suppl. 3): S29-35.
5. Dahlof B. Effect of angiotensin II blocakde on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 1995; 9 (Suppl. 5): S37-44.
6. Taguchi J, Abe J, Okazaki H, et al. Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application. Biochem Biophys Res Commun 1993; 196: 969-74.
7. Clozel JP, Kuhn H, Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989; 7: 267-75.
8. Odori T, Paskins-Hurlburt A, Hollemberg NK. Increase in collateral arterial endothelial cell proliferation induced by captopril after renal artery stenosis in the rat. Hypertension 1983; 5: 307-12.
9. Unger T, Mattfed T, Lamberty V, et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992; 20: 476-82.
10. Schwartz SM, deBlois D, O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995; 77: 445-65.
11. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993; 22 (Suppl. 9): S1-8.
12. Gohlke P, Linz W, Schölkens BA, et al. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension 1994; 23: 411-8.
13. Falkenhahn M, Franke F, Bohle MR, et al. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 1995; 25: 219-26.
14. Gottwik M, Puschmann S, Wuesten B, et al. Myocardial protection by collateral vessels during experimental coronary ligation. A prospective study in a canine two-infarct model. Basic Res Cardiol 1984; 79: 337-43.
15. Tomanek RJ, Wessel TJ, Harrison DG. Capillary growth and geometry during long-term hypertension myocardial hypertrophy in dogs. Am J Physiol 1991; 261: H1011-8.
16. Crisman RP, Rittman B, Tomanek RJ. Exercise-induced myocardial growth in the spontaneously hypertensive rats. Microvasc Res 1985; 30: 185-94.
17. Schaper W, de Brabander M, Levi P. DNA synthesis and mitosis in coronary collateral vessels of the dog. Circ Res 1971; 28: 671-9.
18. Quinkler W, Maasberg M, Bernotat-Danielowski S, et al. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur J Biochem 1989; 181: 67-73.
19. Casscells W, Speir E, Sasse J, et al. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85: 433-41.
20. 2-adrenoreceptors. Br J Pharmacol 1995; 114: 1577-86.
21. Fernandez LA, Twickler Mead A. Neovascularization produced by angiotensin II. Lab Clin Med 1985; 105: 141-5.
22. LeNoble FAC, Schreurs NHJS, van Straaten HWM, et al. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick chorioallantoic membrane. Am J Physiol 1993; 264: R460-5.
23. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989; 13: 305-14.
24. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.
25. Metsärinne KP, Stoll M, Gohlke P, Paul M, Unger T. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharmaceut Pharmacol Lett 1992; 2: 150-2.
26. Timmermanns PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 205-51.
27. Kakar SS, Seller JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun 1992; 183: 1090-6.
28. Sandberg K, Ji H, Clark AJL, Shapira H, Catt KJ. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem 1992; 267: 9455-8.
29. Chiu AT, Dunscomb JH, McCall DE, Benfield P, Baubonis W, Sauer B. Characterization of angiotensin AT1a receptor isoform by its ligand binding signature. Regul Pept 1993; 44: 141-7.
30. Kakar SS, Riel KK, Neill JD. Differential expression of angiotensin II receptor subtype mRNAs (AT-1A) and (AT-1B) in the rat brain. Biochem Biophys Res Commun 1992; 185: 688-92.
31. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 1992; 188: 446-52.
32. Inagami T, Yamano Y, Bardhan S, et al. Cloning, expression and regulation of angiotensin II receptors. Adv Exp Med Biol 1995; 377: 311-7.
33. Höhle S, Blume A, Lebrun C, Culman J, Unger T. Angiotensin receptors in the brain. Pharmacol Toxicol 1995; 77: 306-15.
34. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995; 377: 744-7.
35. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995; 377: 748-50.
36. Ito M, Oliverio MI, Mannon PJ, et al. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995; 92: 3521-5.
37. Chaki S, Inagami T. Identification and characterization of a new binding site for angiotensin II in mouse neuroblastoma neuro-2A cells. Biochem Biophys Res Commun 1992; 182: 388-94.
38. Hall KL, Venkateswan S, Hanesworth JM, Schleiing ME, Harding JW. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 1995; 58: 107-15.
39. 125I]-angiotensin II binding to non-AT1 or non-AT2 recognition sites in bovine adrenal cortex. Eur J Pharmacol 1992; 219: 319-22.
40. Sardinia MF, Hanesworth JM, Krebs LT, Harding J. AT4 receptor binding characteristics: D-amino acid and glycine-substituted peptides. Peptides 1993; 14: 949-54.
41. Roberts KA, Krebs LT, Kramár EA, Shaffer MJ, Harding JW, Wright JW. Autoradiographic identification of brain angiotensin IV binding sites and differential c-fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Res 1995; 682: 13-21.
42. Hjorth SA, Schambye HT, Greenlee WJ, Schwartz TW. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem 1994; 269: 30953-9.
43. Noda K, Saad Y, Kinoshita A, et al. Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by different mechanisms. J Biol Chem 1995; 270: 2284-9.
44. Feng YH, Noda K, Saad Y, Liu XP, Husain A, Karnik SS. The docking of angiotensin with Asp281 of AT1 receptor is essential for full agonism. J Biol Chem 1995; 270: 12846-50.
45. Ohyama K, Yamano Y, Chaki K, et al. Domains for G protein coupling in angiotensin II receptor type 1: studies by site-directed mutagenesis. Biochem Biophys Res Commun 1992; 198: 1426-31.
46. Baukal AJ, Balla T, Hunyady L, et al. Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-triphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem 1988; 263: 6087-92.
47. 2+-sensitive protein kinases in the response of hepatocytes to angiotensin II and vasopressin. J Biol Chem 1984; 259: 3283-92.
48. Naftilan AJ, Pratt RE, Eldridge CS, Dzau VJ. Angiotensin II induces c-fos expression in smooth muscle cells via transcriptional control. Hypertension 1989; 13: 706-11.
49. Kawahara Y, Sunako M, Tsuda T, et al. Angiotensin II induced expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988; 150: 52-9.
50. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle cells. J Biol Chem 1989; 264: 526-30.
51. Marrero MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995; 375: 247-50.
52. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268-74.
53. Catalioto R-M, Porchia R, Renzetti AR, Criscuoli M, Subissi A, Ciachetti A. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists. Eur J Pharmacol 1995; 280: 285-92.
54. Leduc I, Haddad P, Giasson E, Meloche S. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Mol Pharmacol 1995; 48: 582-92.
55. Kambayashi Y, Bardhan S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194: 478-82.
56. Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993; 268: 24543-6.
57. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993; 268: 24539-42.
58. Koike G, Horiuchi M, Yamada T, Szpirer C, Jacob HJ, Dzau VJ. Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA expressed in the human lung. Biochem Biophys Res Commun 1994; 203: 1842-50.
59. Buisson B, Laflamme L, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD. A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J Biol Chem 1995; 270: 1670-4.
60. + currents involves an inhibitory GTP binding protein. Am J Physiol 1994; 267: C607-16.
61. Bottari SP, King IN, Reichlin S, Dahlstroem I, Lydon N, de Gasparo M. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem Biophys Res Commun 1992; 183: 206-11.
62. Stoll M, Steckelings MU, Bottari SP, Unger T. Regulation of endothelial growth - role of the angiotensin II AT2 receptor. Circulation 1993; 88: 1-469.
63. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 10663-7.
64. Meffert S, Stoll M, Unger T. The AT2 receptor inhibits proliferation and promotes differentiation on PC12 W cells in the presence of EGF and NGF. Cell Mol Endocrinol (in press).
65. Steckelings UM, Stoll M, Wagner J, Unger T. Differential expression of immediate early genes via angiotensin receptor subtypes AT1 and AT2. J Hypertens 1994; 12 (Suppl. 3): 396.
66. Trouche D, Grigoriev G, Lenormand JL, et al. Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 1993; 363: 79-82.
67. Unger T, Stoll M, Jonas U, Hahn AWA. Isolation of differentially expressed genes in PC12 W cells after stimulation of AT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 1995; 351 (Suppl.): 472.